Navigation Links
Penn study unlocks origins of blood stem cells
Date:12/9/2011

PHILADELPHIA A research team led by Nancy Speck, PhD, professor of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, has discovered a molecular marker for the immediate precursors of hematopoietic (blood) stem cells (HSCs) in the developing embryo, which provides much-needed insights for making these cells from engineered precursors.

Because HSCs, found in the bone marrow of adult mammals, generate all of the blood cell types of the body, unlocking the secrets of their origin may help researchers to better manipulate embryonic stem cells to generate new blood cells for therapy. Speck is also an Investigator with the Abramson Family Cancer Research Institute at Penn. The work was published this week in Cell Stem Cell.

"The ultimate goal for stem-cell therapies is to take precursor stem cells and push them down a particular lineage to replace diseased or dead cells in human adults or children," says Speck. First things first, she says: "You have to understand how this happens in the embryo."

Previous studies indicated that HSCs originated from a small population of cells lining blood vessels, called endothelial cells. But, it was unclear precisely which endothelial cells transitioned to blood stem cells during early development.

In the embryo, there are multiple waves of blood-cell development. The first wave gives the embryo a quick oxygen source and the final wave sets up the development of HSCs that ultimately reside in adult bone marrow. The first wave of progenitors can be generated in the lab from embryonic or induced pluripotent stem cells, but efforts to produce hematopoietic stem cells have failed, says Speck.

"Understanding the developmental origins of hematopoietic stem cells is important for learning how to produce them in the lab from embryonic or induced pluripotent stem cells," says Speck.

How much closer does this study take hematologists to be able to make HSCs successfully? Scientists can make blood cells from endothelial cells now and can monitor these in the embryo. But not all endothelial cells give rise to HSCs. The team used a special marker to follow the development of HSCs. Progenitor cells in the first wave of embryo blood-cell development and the HSCs of later waves of development differentiate from distinct populations of blood-producing endothelial cells. The marker, called Ly6a, is expressed in the endothelial cells that lead to HSCs, and it is not expressed in endothelial cells that make the first wave of blood cells.

Knowing more about the development of HSCs and its distinct markers will be helpful in making HSCs in the lab for stem-cell therapies so leukemia patients, for example many of whom are unable to find suitable donors could use their own cells to make HSCs and eventually blood cells depleted by blood cancers and some of its treatments.


'/>"/>
Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. Ready-to-bake cookie dough not ready-to-eat, study of E. coli outbreak finds
2. Few With Acute Kidney Injury See Specialists, Study Finds
3. Few Women Get Breast Reconstruction After Mastectomy: Study
4. Treating Prehypertension Lowers Stroke Risk: Study
5. Princeton study: Nighttime images help track disease from the sky
6. Study probes genetic link to sickle cell pain management
7. Rats Can Lend a Helping Paw to Others, Study Finds
8. Study shows species can change
9. Study sheds light on cancer burden in Australia
10. NEJM publishes study showing LigoCytes norovirus vaccine demonstrates protection against illness
11. Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Penn study unlocks origins of blood stem cells
(Date:5/5/2016)... ... May 05, 2016 , ... The University of Western States ... the 2016 National SACA Leadership Conference on the Portland campus September 23-25. The ... to come together and develop skills to be future leaders in the profession. ...
(Date:5/5/2016)... ... ... Vitenas Cosmetic Surgery has been named as one of the eight recipients ... and the Academy of Architecture for Health. The building, brainchild of founder Paul Vitenas, ... in October of 2014. , The prestigious Healthcare Design Awards are ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos ... loss treatment. Dr. Stong is double board certified and the only facial plastic ... treatment of hair loss. Non-surgical therapies such as stem cells can be used to ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... In honor ... firm, is encouraging people all over the United States to thank a nurse who's ... Aya Healthcare will donate $5 to the American Red Cross of San Diego/Imperial Counties ...
(Date:5/5/2016)... ... ... Chronic stress can have a silent, yet dangerous, impact on men’s heart ... increase inflammation, both of which raise the risk of heart attack and even stroke,” ... Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead to other issues that indirectly ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... NEW YORK , May 4, 2016 ... Size, Share, Development, Growth and Demand Forecast to 2022 - ... End User (Hospital, Diagnostic Center and Others)" by P&S Market ... at $4,894.3 million in 2015, and it is expected to ... slice type, the high slice type segment is expected to ...
(Date:5/4/2016)... D.C. , May 4, 2016 ... member companies concluded a series of free workshops ... in global requirements for Good Distribution ... of quality assurance which ensures that products are consistently stored, ... the marketing authorization (MA) or product specification. Only a ...
(Date:5/4/2016)... 4, 2016 Research ... "Global Multiple Myeloma Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Competitive Landscape Highlights 2016, provides comprehensive insights ... epidemiology, Multiple Myeloma market valuations and forecast, ...
Breaking Medicine Technology: